Tylenol is owned by Kenvue, an American consumer health company that was spun off from Johnson & Johnson in 2023. Kenvue became an independent publicly traded company and now manufactures Tylenol along with other well-known consumer health brands. The company is headquartered in Summit, New Jersey. Tylenol was originally introduced in 1955 by McNeil Laboratories, which Johnson & Johnson acquired in 1959 before eventually spinning off the consumer health division as Kenvue.
